Effects of complement factor D deficiency on the renal disease of MRL/lpr mice

被引:94
作者
Elliott, MK
Jarmi, T
Ruiz, P
Xu, YY
Holers, VM
Gilkeson, GS
机构
[1] Univ Nebraska, Med Ctr, Dept Internal Med, Omaha, NE USA
[2] Med Univ S Carolina, Dept Med, Ralph H Johnson VA Med Ctr, Res Serv, Charleston, SC 29425 USA
[3] Univ Miami, Sch Med, Dept Pathol, Miami, FL USA
[4] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA
[5] Univ Colorado, Dept Med, Denver, CO USA
[6] Univ Colorado, Dept Immunol, Denver, CO USA
关键词
lupus nephritis; animal models; complement alternative pathway;
D O I
10.1111/j.1523-1755.2004.00371.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. The alternative complement pathway (AP) is activated in individuals with lupus nephritis and in murine models of systemic lupus erythematosus, including MRL/lpr mice. A previous study from our laboratory evaluated the development of renal disease in MRL/lpr mice genetically deficient in factor B (Bf-/-), a protein necessary for AP activation. MRL/lpr Bf-/- mice developed less renal disease and had improved survival; however, these mice were also a different major histocompatibility complex (MHC) haplotype (H-2(b)) than their wild-type littermates (H-2(k)) due to the gene for Bf being located in the MHC gene complex. We undertook the current study to determine if the decreased renal disease in MRL/lpr Bf-/- mice was due to the lack of AP activation or the H-2(b) haplotype by studying the effects of factor D(Df) deficiency, a critical protein for AP activation, on disease development in MRL/lpr mice. Methods. Df-deficient mice were backcrossed with MRL/lpr mice for four to nine generations. MRL/lpr H-2(k) Df-/-,Df+/-, and Df +/+ littermates were evaluated for disease development. Lack of AP activation in MRL/lpr Df-/- mice was determined by the zymosan assay. Serum creatinine levels were measured using a creatinine kit. Proteinuria and autoantibody levels were determined by enzyme-linked immunosorbent assay (ELISA). Sections from one kidney were stained with fluorescein isothiocyanate (FITC) alpha-murine C3 or alpha-murine IgG to detect C3 and IgG deposition. The remaining kidney was cut in half with one half fixed, sectioned, and stained with hematoxylin and eosin and periodic acid-Schiff (PAS) to evaluate pathology and another half fixed in glutaraldehyde and examined via electron microscopy. Results. MRL/lpr Df-/- mice had similar glomerular IgG deposition, proteinuria and autoantibody levels, as Df+/+ and Df+/- littermates. However, glomerular C3 deposition, serum creatinine levels, and pathologic renal disease were significantly reduced in Df-/- mice. Despite the lack of renal disease in Df-/- mice, life span was not impacted by factor D deficiency. Conclusion. The absence of Df and AP activation is protective against the development of proliferative renal disease in MRL/lpr mice suggesting the similar effect of Bf deficiency in MRL/lpr mice was also due to the lack of AP activation.
引用
收藏
页码:129 / 138
页数:10
相关论文
共 46 条
[1]   Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen [J].
Ahearn, JM ;
Fischer, MB ;
Croix, D ;
Goerg, S ;
Ma, MH ;
Xia, JR ;
Zhou, XN ;
Howard, RG ;
Rothstein, TL ;
Carroll, MC .
IMMUNITY, 1996, 4 (03) :251-262
[2]   Expression of complement regulatory proteins in diffuse proliferative glomerulonephritis [J].
Arora, M ;
Arora, R ;
Tiwari, SC ;
Das, N ;
Srivastava, LM .
LUPUS, 2000, 9 (02) :127-131
[3]   Factor H and the pathogenesis of renal diseases [J].
Ault, BH .
PEDIATRIC NEPHROLOGY, 2000, 14 (10-11) :1045-1053
[4]  
BERNSTEIN KA, 1995, J IMMUNOL, V154, P2424
[5]   RENAL LOCALIZATION OF THE MEMBRANE ATTACK COMPLEX IN SYSTEMIC LUPUS-ERYTHEMATOSUS NEPHRITIS [J].
BIESECKER, G ;
KATZ, S ;
KOFFLER, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1981, 154 (06) :1779-1794
[6]   C1q knock-out mice for the study of complement deficiency in autoimmune disease [J].
Botto, M .
EXPERIMENTAL AND CLINICAL IMMUNOGENETICS, 1998, 15 (04) :231-234
[7]  
Buerke M, 1998, J PHARMACOL EXP THER, V286, P429
[8]   Novel small molecule inhibitor of C1s exerts cardioprotective effects in ischemia-reperfusion injury in rabbits [J].
Buerke, M ;
Schwertz, H ;
Seitz, W ;
Meyer, J ;
Darius, H .
JOURNAL OF IMMUNOLOGY, 2001, 167 (09) :5375-5380
[9]   Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2 [J].
Chen, ZB ;
Koralov, SB ;
Kelsoe, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (09) :1339-1351
[10]   Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils [J].
de Vries, B ;
Köhl, J ;
Leclercq, WKG ;
Wolfs, TGAM ;
van Bijnen, AAJHM ;
Heeringa, P ;
Buurman, WA .
JOURNAL OF IMMUNOLOGY, 2003, 170 (07) :3883-3889